Migraine Treatment Report

www.MigraineTreatmentReport.com

Pending

  • Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
  • Interictal amylin levels in chronic migraine patients: A case-control study.
  • Latest Insights into the Pathophysiology of Migraine: the ATP-Sensitive Potassium Channels.
  • Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial.
  • Management of Primary Headaches in Pregnancy
  • Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study.
  • Randomized Study in Children and Adolescents With Migraine: Acute Treatment
  • Cerebral fractional amplitude of low-frequency fluctuations may predict headache intensity improvement following acupuncture treatment in migraine patients.
  • Alleviation of migraine symptoms by application of repetitive peripheral magnetic stimulation to myofascial trigger points of neck and shoulder muscles – A randomized trial.
  • Quality improvement in neurology: Headache Quality Measurement Set.
  • Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study.
  • Increase in trigeminal ganglion neurons that respond to both CGRP and PACAP in mouse models of chronic migraine and post-traumatic headache.
  • Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.
  • Headaches in Adults in Primary Care: Evaluation, Diagnosis, and Treatment.
  • Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and Migraine.
  • Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial.
  • Flunarizine, a drug approved for treating migraine and vertigo, exhibits cytotoxicity in GBM cells.
  • The Spontaneous Activity Pattern of the Middle Occipital Gyrus Predicts the Clinical Efficacy of Acupuncture Treatment for Migraine Without Aura.
  • Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study.
  • Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications.
  • Pharmacoeconomic Review Report: OnabotulinumtoxinA (Botox): (Allergan Inc.): Indication: For the prophylaxis of headaches in adults with chronic migraine (≥ 15 days per month with headache lasting four hours a day or longer)
  • Low Intensity, Transcranial, Alternating Current Stimulation Reduces Migraine Attack Burden in a Home Application Set-Up: A Double-Blinded, Randomized Feasibility Study.
  • A Review on the Triggers of Pediatric Migraine with the Aim of Improving Headache Education.
  • Turbinate Submucosal Reduction Operation Reduced Migraine Admission among Patients with Chronic Hypertrophic Rhinitis.
  • Nystagmus and Vertigo in Acute Vestibular Migraine Attacks: Response to Non-Invasive Vagus Nerve Stimulation.
  • A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention.
  • Calcitonin Gene-Related Peptide Monoclonal Antibody Use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.
  • Radiofrequency Ablation for Treating Headache: a Follow-up Study.
  • Update on Calcitonin Gene-Related Peptide Antagonism in the Treatment of Migraine.
  • An Investigation into the Prevalence of Migraine and Its Prophylactic Treatment Patterns in the Czech Republic: An Observational Study.
  • Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine.
  • [Response prediction for chronic migraine preventive treatment by gray matter morphometry in magnetic resonance imaging: a pilot study].
  • The effects of two different intensities of aerobic training protocols on pain and serum neuro-biomarkers in women migraineurs: a randomized controlled trail.
  • Study the Effect of Acupuncture on Migraine Patient Without Aura Via Functional Magnetic Resonance Imaging.
  • Sodium valproate in paediatric migraine.
  • The use of anti-epileptic drugs in prevention of migraine in children and adolescents.
  • Evidence of new-onset depression among persons with migraine after discontinuing antidepressants.
  • Individual pain sensitivity is associated with resting-state cortical activities in healthy individuals but not in patients with migraine: a magnetoencephalography study.
  • Inpatient infusion treatments of headache in patients with chronic migraine and a reported history of head trauma and endocrine co-morbidities.
  • Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial.
  • De novo protein synthesis is necessary for priming in preclinical models of migraine.
  • Remission of Primary Headache Associated With Sexual Activity in a Woman After Chiropractic Spinal Manipulation: A Case Study.
  • The Prevalence of Migraine With Anxiety Among Genders.
  • Efficacy of Topiramate Alone and Topiramate Plus Vitamin D3 in the Prophylaxis of Pediatric Migraine: A Randomized Clinical Trial.
  • The impact of an online adult headache guideline on headache referrals to neurology clinic.
  • An unusual postural headache: a case report.
  • Interventional Procedures in Episodic Migraine.
  • Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.
  • Migraine Prophylaxis Using Novel Monoclonal Antibody Injections in a Commercial Pilot.
  • Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine.
  • Effectiveness and tolerability of repetitive transcranial magnetic stimulation for preventive treatment of episodic migraine: a single-centre, randomised, double-blind, sham-controlled phase 2 trial (Magnet-EM).
  • Headache management in a Veteran population: First considerations.
  • OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia.
  • Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache.
  • Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study.
  • Differential Expression of Cytokine-Coding Genes among Migraine Patients with and without Aura and Normal Subjects.
  • Therapeutic targeting of nitroglycerin-mediated trigeminovascular neuronal hypersensitivity predicts clinical outcomes of migraine abortives.
  • Peripheral Occipital Nerve Decompression Surgery in Migraine Headache.
  • Synergistic but separable sensory changes in postural tachycardia syndrome and chronic migraine.
  • Decompression Surgery for Frontal Migraine Headache.
  • Reply: No grey matter alterations in longitudinal data of migraine patients.
  • Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease.
  • Prevalence and characteristics of Alice in Wonderland Syndrome in adult migraineurs: Perspectives from a tertiary referral headache unit.
  • Menstrual and perimenopausal migraine: A narrative review.
  • [Chronic and Refractory Migraine: How to Diagnose and Treat].
  • Headache Disparities in African Americans: A Narrative Review and Response to the National Institute of Neurological Disorders and Stroke Request for Information on Neurological Disparities in the United States.
  • Acute Confusional Migraine: Unusual Great Masquerader-Case Report and Literature Review.
  • Female Gender Is Associated with a Higher Prevalence of Chronic Neck Pain, Chronic Low Back Pain, and Migraine: Results of the Spanish National Health Survey, 2017.
  • Treatment patterns and medication adherence among newly diagnosed patients with migraine: a drug utilisation study.
  • Central sensitization in migraine is related to restless legs syndrome.
  • Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
  • Pupil-sparing cranial nerve III palsy after intranasal cocaine treatment for cluster headache.
  • A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
  • TelemEdiciNe-bAsed Cognitive TherapY for Migraines
  • Is the presence of neck pain associated with more severe clinical presentation in patients with migraine? A cross-sectional study.
  • Impact of right-to-left shunt and transcatheter closure on the clinical features of migraine.
  • Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine – temporal relation to bleeding and hormone withdrawal: a prospective diary-based study.
  • Patients with chronic migraine without history of medication overuse are characterized by a peculiar white matter fiber bundle profile.
  • Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
  • The Interconnections of Mal de Débarquement Syndrome and Vestibular Migraine.
  • Auricular acupuncture for migraine: A protocol for systematic review and meta-analysis.
  • Proposal of a clinical care pathway for quality and safe management of headache patients: a consensus study report.
  • Effects of Procedural Discomfort and Expectation of Benefit on Therapy Continuation in Chronic Migraine Patients Treated With OnabotulinumtoxinA.
  • The potentials of Uncariae Ramulus Cum Uncis for treatment of migraine: Targeting CGRP in the trigeminovascular system.
  • OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients.
  • Hospital-based headache care during the Covid-19 pandemic in Denmark and Norway.
  • Optimal treatment strategy of fremanezumab in migraine prevention: a systematic review with network meta-analysis of randomized clinical trials.
  • Habitual sleep disturbances and migraine: a Mendelian randomization study.
  • Erenumab and OnabotulinumtoxinA Combination Therapy for the Prevention of Intractable Chronic Migraine without Aura: A Retrospective Analysis.
  • Migraine variants: Nursing considerations.
  • The Prevalence of Different Types of Headache in Patients with Subjective Tinnitus and Its Influence on Tinnitus Parameters: A Prospective Clinical Study.
  • The effectiveness and value of novel acute treatments for migraine.
  • A cross-sectional study on the burden and impact of migraine on work productivity and quality of life in selected workplaces in the Philippines.
  • Migraine and sleep disorders: a systematic review.
  • Statin for Migraine Headache: Is It Worthwhile?
  • α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia.
  • Triptanophobia in migraine: A case-control study on the causes and consequences of the non-use of triptans in chronic migraine patients.
  • Migraine headache: Is it only a neurological disorder? Links between migraine and cardiovascular disorders.
  • Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population.
  • Migraine Treatment in Emergency Departments of Brazil: A Retrospective Study of 2 Regions.
  • The diagnostic accuracy of headache measurement instruments: A systematic review and meta-analysis focusing on headaches associated with musculoskeletal symptoms.
  • The Burden of Migraine in Adults with Atrial Septal Defect: A Nationwide Cohort Study.
  • Comments on “The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study” by de Roos et al.
  • Pyridoxine, folate and cobalamin for migraine: A systematic review.
  • Headache characteristics in COVID-19 pandemic-a survey study.
  • [Erratum: Novel migraine treatment with CGRP-related monoclonal antibodies].
  • Valproic Acid in the Treatment of Migraines.
  • Diagnosis and Treatment of Headache in a Pediatric Emergency Department.
  • Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine
  • Registry for Migraine – Clinical Core
  • Impulse control disorders in chronic migraine with medication overuse after onabotulinumtoxinA: A single-center prospective cohort study.
  • Migraine neuroscience: from experimental models to target therapy.
  • A prospective study of headache and neuropeptides in patients with pituitary adenomas.
  • Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis.
  • Thymoquinone Inhibits Neurogenic Inflammation Underlying Migraine Through Modulation of Calcitonin Gene-Related Peptide Release and Stabilization of Meningeal Mast Cells in Glyceryltrinitrate-Induced Migraine Model in Rats.
  • Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data.
  • How to diagnose and treat benign headaches.
  • Clinical characteristics of pre-attack symptoms in cluster headache: A large series of Korean patients.
  • A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB.
  • Case report: Migraine that persisted for over 20 years disappears after treatment for pulmonary arteriovenous fistula.
  • Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.
  • Clinical use of omega-3 fatty acids in migraine: A narrative review.
  • Brain structure and function related to headache: Brainstem structure and function in headache.
  • Current understanding of trigeminal ganglion structure and function in headache.
  • Functional connectivity of hypothalamus in chronic migraine with medication overuse.
  • Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.
  • The role of stress and psychiatric comorbidities as targets of non-pharmacological therapeutic approaches for migraine.
  • Non-invasive Nerve Stimulation Modalities for Migraine Pain: A Review of Clinical Effectiveness and Cost-effectiveness
  • Aneurysmal subarachnoid hemorrhage in patients with migraine and tension headache: A cohort comparison study.
  • Combined hormonal contraception and migraine: are we being too strict?
  • Patient Pain Sketches Can Predict Surgical Outcomes in Trigger-Site Deactivation Surgery for Headaches.
  • The unique demands of childhood migraine.
  • A visual guide to migraine headaches.
  • Botulinum toxin injection in the management of chronic migraine: the Saudi experience with a proposal for a new protocol.
  • No additive effect of combining sumatriptan and olcegepant in the GTN mouse model of migraine.
  • Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies.
  • Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
  • Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials).
  • Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
  • Effect of the H1-antihistamine clemastine on PACAP38 induced migraine.
  • Benefit-risk assessment of erenumab and current migraine prophylactic treatments using the likelihood of being helped or harmed.
  • The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial.
  • Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
  • [Clinical characteristics analysis of patients with Meniere’s disease and vestibular migraine].
  • Tuling Wendan Decoction combined with flunarizine in the treatment of migraine patients and the effect of intervention on serum cyclooxygenase-2, endothelin-1 and nitric oxide.
  • MAGraine: Magnesium compared to conventional therapy for treatment of migraines.
  • The impact of midlife on migraine in women: summary of current views.
  • Treatment patterns, health resource consumption, and costs of patients with migraine in an Italian real-world setting.
  • Automated Variable Pattern Insufflator Device (AVPI) for the Acute Treatment of Migraine
  • Neonatal abstinence syndrome and intra-uterine growth restriction secondary to maternal antimigraine drug abuse.
  • Cluster Headache: Opportunities for Pharmacists to Improve Care.
  • Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
  • Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.
  • The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine.
  • Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis.
  • The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties.
  • Efficacy of OnabotulinumtoxinA in Migraine
  • Primaries non-migraine headaches treatment: a review.
  • Are Retinal and Peripapillary Blood Flows Affected during Migraine Attack?
  • Hejie Zhitong prescription promotes sleep and inhibits nociceptive transmission-associated neurotransmitter activity in a rodent migraine model.
  • The impact of remission and coexisting migraine on anxiety and depression in cluster headache.
  • European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA).
  • Risk of Acute Myocardial Infarction, Heart Failure, and Death in Migraine Patients Treated with Triptans.
  • Candesartan for Migraine Prevention:
  • Update in migraine preventive treatment.
  • A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
  • Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine-The monoclonal antibodies and gepants.
  • OnabotulinumtoxinA injection in the treatment of chronic migraine.
  • The visual system as target of non-invasive brain stimulation for migraine treatment: Current insights and future challenges.
  • Update on noninvasive neuromodulation for migraine treatment-Vagus nerve stimulation.
  • Managing migraine in pregnancy and breastfeeding.
  • Therapeutic implications of cortical spreading depression models in migraine.
  • Targeting migraine treatment with neuroimaging-Pharmacological neuroimaging in headaches.
  • Therapeutic role of melatonin in migraine prophylaxis: Is there a link between sleep and migraine?
  • Clinical and biobehavioral perspectives: Is medication overuse headache a behavior of dependence?
  • Targeting the 5-HT1B/1D and 5-HT1F receptors for acute migraine treatment.
  • Sex and the serotonergic underpinnings of depression and migraine.
  • An Evidence-Based Review of Galcanezumab for the Treatment of Migraine.
  • Pharmacological strategies to treat attacks of episodic migraine in adults.
  • Pharmacological options for the treatment of chronic migraine pain.
  • Utilization of B12 for the treatment of chronic migraine.
  • [Digitalization in headache therapy].
  • A pragmatic case series of clients living with medically diagnosed migraines self-referred to reflexology.
  • Out-of-hospital assessment and treatment of adults with atraumatic headache.
  • Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine
  • Serotonin Syndrome: A Real Risk of Anti-migraine Therapy.
  • Short-term Efficacy and Safety of Topical β-Blockers (Timolol Maleate Ophthalmic Solution, 0.5%) in Acute Migraine: A Randomized Crossover Trial.
  • Acupuncture and Its Role in the Treatment of Migraine Headaches.
  • Novel Therapies in Acute Migraine Management: Small-Molecule Calcitonin Gene-Receptor Antagonists and Serotonin 1F Receptor Agonist.
  • Long-Term Outcomes of Occipital Nerve Stimulation for New Daily Persistent Headache With Migrainous Features.
  • Omega-3 Fatty Acid in the Prevention of Migraine
  • Randomized Trial in Adult Subjects With Acute Migraines
  • Clinician-Patient Dialogue About Preventive Chronic Migraine Treatment.
  • Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension.
  • Migraine Treatment in Pregnancy: An American Headache Society Survey.
  • Erenumab in Chronic Migraine: An Australian Experience.
  • What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian Chronic Migraine Group.
  • Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review.
  • A Randomized, Double-Dummy, Emergency Department-Based Study of Greater Occipital Nerve Block With Bupivacaine vs Intravenous Metoclopramide for Treatment of Migraine.
  • Migraine Disability, Quality of Life, and Its Predictors.
  • A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
  • Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
  • Post-traumatic cephalalgia.
  • Migraine STImulation Crisis of Migraine
  • Migraine Manager (R01)
  • Efficacy and Feasibility of Behavioral Treatments for Migraine, Headache, and Pain in the Acute Care Setting.
  • Intravenous Chlorpromazine as Potentially Useful Treatment for Chronic Headache Disorders.
  • Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study.
  • Endogenous glucocorticoids may serve as biomarkers for migraine chronification.
  • Symptom Clusters and Functional Impairment in Individuals Treated for Lyme Borreliosis.
  • Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study.
  • Use of outpatient medical care by headache patients in Germany: a population-based cross-sectional study.
  • Functional gene networks reveal distinct mechanisms segregating in migraine families.
  • Medicines for headache before and during pregnancy: a retrospective cohort study (ATENA study).
  • The Efficacy of Lasmiditan for the Treatment of Migraine: A Meta-Analysis of Randomized Controlled Studies.
  • Melatonin for Acute Treatment of Migraine in Children and Adolescents: A Pilot Randomized Trial.
  • Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial.
  • Effectiveness, Safety, and Health-Related Quality of Life of Chronic Migraine Patients Treated with Onabotulinum Toxin A.
  • Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache.
  • The relation between the placebo response, observed treatment effect, and failure to meet primary endpoint: A systematic review of clinical trials of preventative pharmacological migraine treatments.
  • [Real need for headache services and their resource consumption: a retrospective observational study on a cohort in Cantabria].
  • Image Gallery: Recurrent headache and facial ecchymosis.
  • The reporting quality and risk of bias of randomized controlled trials of acupuncture for migraine: Methodological study based on STRICTA and RoB 2.0.
  • The Impact of Soft Tissue Techniques in the Management of Migraine Headache: A Randomized Controlled Trial.
  • Vitamin B12 and folic acid levels in pediatric migraine patients.
  • Predicting the response to a triptan in migraine using deep attack phenotyping: A feasibility study.
  • Acute Care Treatment of Migraine.
  • Smartphone based behavioral therapy for pain in multiple sclerosis (MS) patients: A feasibility acceptability randomized controlled study for the treatment of comorbid migraine and ms pain.
  • Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
  • Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.
  • [Migraine prophylaxis-all just antibodies? : Medical and nonmedical migraine preventive treatment in times of CGRP antibodies].
  • Headaches in hypermobility syndromes: A pain in the neck?
  • Advocacy in Headache Medicine: Tips at the Bedside, the Institutional Level, and Beyond.
  • Temporal, Environmental, and Genetic Factors Regulating Exercise and Migraine
  • Real-world Experience with Remote Electrical Neuromodulation in the Acute Treatment of Migraine.
  • Subgrouping Factors Influencing Migraine Intensity in Women: A Semi-automatic Methodology Based on Machine Learning and Information Geometry.
  • Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN).
  • Eptinezumab (Vyepti) for migraine prevention.
  • [Tension type headaches : Quo vadis?]
  • Intravenous Nimodipine Treatment for Severe Episode of ATP1A2 Hemiplegic Migraine.
  • Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine.
  • Medicinal vs. Orthotic Comparison for Migraine Prevention: A Double-Blind Study
  • Central effects of erenumab in migraine patients: An event-related functional imaging study.
  • Profiling the Extent and Location of Pain in Migraine and Cervicogenic Headache: A Cross-sectional Single-Site Observational Study.
  • Patterns of Perceived Stress Throughout the Migraine Cycle: A Longitudinal Cohort Study Using Daily Prospective Diary Data.
  • Exploring Emotional Distress, Psychological Traits and Attitudes in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylaxis versus Withdrawal Treatment.
  • LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF FREMANEZUMAB IN MIGRAINE: A RANDOMIZED STUDY.
  • Rimegepant Orally Disintegrating Tablet for Acute Migraine Treatment: A Review.
  • Occipital Nerve Stimulation in Chronic Migraine: The Relationship Between Perceived Sensory Quality, Perceived Sensory Location, and Clinical Efficacy-A Prospective, Observational, Non-Interventional Study.
  • Complementary and alternative medicine (CAM) in headache of children and adolescents: open-label Italian study.
  • Evaluation of green light exposure on headache frequency and quality of life in migraine patients: A preliminary one-way cross-over clinical trial.
  • Onset of action in placebo-controlled migraine attacks trials: A literature review and recommendation.
  • Yoga as an Add-on Therapy in the Management of Migraine.
  • ACUPUNCTURE IN MIGRAINE WITHOUT AURA PATIENTS
  • [Migraine – more than a headache].
  • Combination therapy in migraine: asset or issue?
  • [Novel migraine treatment with CGRP-related monoclonal antibodies].
  • Management of Chronic Migraine in Children and Adolescents: A Brief Discussion on Preventive Therapies.
  • Disentangling placebo effects in the treatment of migraine.
  • Acupuncture versus Various Control Treatments in the Treatment of Migraine: A Review of Randomized Controlled Trials from the Past 10 Years.
  • Evaluating the effect of Coriandrum sativum syrup on being migraine-free using mixture models.
  • Moving closer to the ideal migraine acute treatment.
  • The treatment implications of forecasting headache.
  • Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression.
  • Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate.
  • Effect of circadian rhythm on the pain associated with preventive onabotulinumtoxinA injections for migraines.
  • Improving Acute Treatment of Pediatric Primary Headache Disorders With a Novel Headache Treatment Center: Retrospective Review of Preliminary Outcomes.
  • Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review.
  • Review of aromatherapy essential oils and their mechanism of action against migraines.
  • A Study in Children and Teenagers With Migraine to Learn What the Body Does to Eptinezumab
  • Cardiovascular fitness and risk of migraine: a large, prospective population-based study of Swedish young adult men.
  • Erenumab does not alter cerebral hemodynamics and endothelial function in migraine without aura.
  • Reason to doubt the ICHD-3 7-day inclusion criterion for mild TBI-related posttraumatic headache: A nested cohort study.
  • Rimegepant (Nurtec ODT) for Acute Treatment of Migraine.
  • Basic and Clinical Advances in the Diagnosis and Management of Migraine.
  • The probiotic Lactobacillus casei Shirota attenuates symptoms of vestibular migraine: a randomised placebo-controlled double-blind clinical trial.
  • Classical Clinical and Neuroimaging Findings in SMART (Stroke-Like Migraine Attacks after Radiation Therapy) Syndrome.
  • Intrarater and Interrater Reliability of the Flexion Rotation Test and Cervical Range of Motion in People With Migraine.
  • Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT-6) Total and Item-Specific Scores in Chronic Migraine.
  • Ibuprofen in Migraine Patients
  • Lasmiditan for Acute Treatment of Migraine in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
  • Exploring new strategy in erenumab therapy for migraine patients.
  • Mindfulness as an add-on treatment for patients with chronic migraine and medication overuse: a preliminary analysis.
  • Safety and efficacy of galcanezumab in Taiwanese Patients: a post-hoc analysis of phase 3 studies in episodic and chronic migraine.
  • The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response.
  • A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
  • Headache in idiopathic intracranial hypertension. A CGRP-dependent head pain?
  • Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison.
  • Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children.
  • Migraine treatment and the risk of postoperative, pain-related hospital readmissions in migraine patients.
  • Headaches during pregnancy.
  • Efficacy of acupuncture for migraine prophylaxis: a trial sequential meta-analysis.
  • [Analysis of clinical features of vestibular migraine].
  • Short-latency afferent inhibition and somato-sensory evoked potentials during the migraine cycle: surrogate markers of a cycling cholinergic thalamo-cortical drive?
  • Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report.
  • Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine.
  • MRI in migraineurs: are there abnormalities in the area where the myofascial trigger points are palpable and in volume measurements?
  • The Effect of Nano-Curcumin Supplementation on Pentraxin 3 Gene Expression and Serum Level in Migraine Patients.
  • Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial.
  • An Evaluation of Brief Online Hypnosis for Migraine and Chronic Tension-headaches
  • Osteopathic Manipulative Techniques for the Treatment of Chronic Migraine Headaches
  • Vascular actions of peripheral CGRP in migraine-like photophobia in mice.
  • CGRP inhibitors for migraine prophylaxis: a safety review.
  • Mesotherapy Versus Systemic Therapyin Treatment of Migraine Headache
  • Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
  • Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts.
  • Corrigendum to “Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults”.
  • Differential medication overuse risk of novel anti-migraine therapeutics.
  • Self-reported sinus headaches are associated with neck pain and cervical musculoskeletal dysfunction: a preliminary observational case control study.
  • Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.
  • Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region.
  • A Novel Diagnostic Prediction Model for Vestibular Migraine.
  • Nummular Headache and Its Surgical Treatment.
  • An Update on Idiopathic Hypertrophic Cranial Pachymeningitis for the Headache Practitioner.
  • Migraine and menopause – a narrative review.
  • Wear-Off of OnabotulinumtoxinA Effect Over the Treatment Interval in Chronic Migraine: A Retrospective Chart Review With Analysis of Headache Diaries.
  • Extensor/flexor ratio of neck muscle strength and electromyographic activity of individuals with migraine: a cross-sectional study.
  • Lasmiditan in patients with common migraine comorbidities: a post hoc efficacy and safety analysis of two Phase 3 randomized clinical trials.
  • The status and high risk factors of severe psychological distress in migraine patients during nCOV-2019 outbreak in Southwest China: a cross-sectional study.
  • Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway.
  • The Influence of Photophobia on Postural Control in Patients With Migraine.
  • The use of pharmacological preventive therapy for migraine with weight gain potential amid COVID-19 pandemic.
  • Use of CGRP receptor blocker erenumab in the management of post-traumatic headache: a case series of 5 women.
  • More precise phenotyping of cluster headache using prospective attack reports.
  • Correction to: Intravenous Migraine Treatment in Children and Adolescents.
  • Acupuncture as Migraine Prophylaxis in Reducing Frequency, Duration and Intensity of Migraine With Minimum Acupoint, Seen up to Eight Weeks From Baseline
  • Identification of neural and psychophysical predictors of headache reduction following cognitive behavioral therapy in adolescents with migraine.
  • The effect of intermittent hypoxia training on migraine: a randomized controlled trial.
  • Cortical and subcortical changes following sphenopalatine ganglion blocks in chronic migraine with medication overuse headache: a preliminary longitudinal study.
  • Migraine and other headache disorders in pregnancy.
  • Acupuncture reduced the medical expenditure in migraine patients: Real-world data of a 10-year national cohort study.
  • Management of Menstrual Migraine.
  • Site V Surgery for Temporal Migraine Headaches.
  • Management of Migraine and the Accessibility of Specialist Care: Findings from an Extended Multinational Survey (My Migraine Center Survey).
  • Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention.
  • Alleviative effects of Cannabis flower on migraine and headache.
  • Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
  • Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine.
  • Acupoint catgut embedding for patients with migraine: A protocol for systematic review.
  • A new biofeedback approach for the control of awake bruxism and chronic migraine headache: utilization of an awake posterior interocclusal device.
  • Access to Migraine Treatments in Ontario, Canada: A Review of the Ontario Drug Benefit Program.
  • Patient Reported Ease-of-Use with a Disposable Autoinjector in Individuals with Migraine.
  • Levels and determinants of knowledge about chronic migraine diagnosis and management among primary health-care physicians in ministry of health, Jeddah 2019.
  • OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine.
  • Development of a novel zolmitriptan intracutaneous microneedle system (Qtrypta™) for the acute treatment of migraine.
  • A Study of LY3451838 in Participants With Migraine
  • The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.
  • Efficacy and safety of erenumab in women with a history of menstrual migraine.
  • Effect of Fremanezumab on Quality of Life and Productivity in Patients With Chronic Migraine.
  • A Qualitative Study to Assess the Content Validity of the 24-Hour Migraine Quality of Life Questionnaire in Patients with Migraine.
  • Emerging Evidence for Non-Invasive Vagus Nerve Stimulation for the Treatment of Vestibular Migraine.
  • Vestibular migraine without headache treated with lomerizine: A 35-year-old woman undiagnosed for 10 years.
  • The Efficacy of Surgical Treatment for Headaches in Patients with Prior Head or Neck Trauma.
  • A Comprehensive Review of Surgical Treatment of Migraine Surgery Safety and Efficacy.
  • Intravenous Sodium Valproate for Acute Migraine in the Emergency Department: A meta-analysis.
  • Objectively Measured Physical Activity in Migraine as a Function of Headache Activity.
  • Iron Deposits in Periaqueductal Gray Matter Are Associated with Poor Response to OnabotulinumtoxinA in Chronic Migraine.
  • The Ambiguous Role of Caffeine in Migraine Headache: From Trigger to Treatment.
  • Vestibular Neuroscience for the Headache Specialist.
  • Anti-Neuroinflammatory Properties of n-3 Fatty Acids and Nano-Curcumin on Migraine Patients, from Cellular to Clinical Insight: A Randomized, Double Blind, and Placebo-Controlled Trial.
  • Abdominal migraines: Variations in diagnosis and care between pediatric gastroenterologists and neurologists.
  • Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants
  • PFO Closure and Migraine: Does Residual Shunt Matter?
  • Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.
  • Efficacy of Occipital Nerve Stimulation to Treat Refractory Occipital Headaches: A Single-Institution Study of 60 Patients.
  • Comparison of Great Occipital Nerve and Supraorbital Nerve Blockade Methods at Treatment of Acute Migraine Attack in the Emergency Department
  • Non-invasive vagus nerve stimulation for primary headache: A clinical update.
  • Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery.
  • Correction to: Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache.
  • Patients With Vestibular Migraine are More Likely to Have Occipital Headaches than those With Migraine Without Vestibular Symptoms.
  • Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine.
  • A Systematic Review and Meta-analysis of the Therapeutic Effect of Acupuncture on Migraine.
  • Migraine and Two-Pore-Domain Potassium Channels.
  • Googling migraine: A study of Google as an information resource of migraine management.
  • The migraine landscape on YouTube: A review of YouTube as a source of information on migraine.
  • Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway.
  • Differences in topological properties of functional brain networks between menstrually-related and non-menstrual migraine without aura.
  • Propofol for migraine in the emergency department: A pilot randomised controlled trial.
  • An update on acute and preventive treatments for migraine in children and adolescents.
  • Enhanced mindfulness-based stress reduction in episodic migraine: a randomized clinical trial with magnetic resonance imaging outcomes.
  • Galcanezumab for the prevention of Cluster Headache.
  • A Popperian View on Anti-CGRP Biologics in Migraine.
  • Pediatric Migraine Action Plan (PedMAP).
  • The Development of the Pediatric Migraine Action Plan (PedMAP).
  • OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection.
  • Retinal migraine.
  • Treatment and management of migraine in neurological ambulatory practice in Poland by indicating therapy with monoclonal anti-CGRP antibodies.
  • Acceptance and Commitment Therapy for Primary Headache Sufferers: A Randomized Controlled Trial of Efficacy.
  • [Non-invasive neurostimulation in migraine].
  • Effect of Headache-Free Days on Disability, Productivity, Quality of Life, and Costs Among Individuals with Migraine.
  • Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine.
  • Is There an Association Between Migraine and Major Depressive Disorder? A Narrative Review.
  • Vestibular Migraine Following Radiosurgery for Vestibular Schwannoma.
  • Periorbital botulinum toxin A improves photophobia and sensations of dryness in patients without migraine: Case series of four patients.
  • Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence.
  • Efficacy and Contextual (Placebo) Effects of CGRP Antibodies for Migraine: Systematic Review and Meta-analysis.
  • Is Mindfulness-Based Stress Reduction a Promising and Feasible Intervention for Patients Suffering from Migraine? A Randomized Controlled Pilot Trial.
  • Pain freedom after 2 hours should be the primary outcome in controlled trials treating migraine attacks.
  • Stroke-like migraine attacks after radiation therapy (SMART) syndrome-a case series and review.
  • Lasmiditan Is a New Option for Acute Migraine Treatment.
  • Recent Evidence Regarding the Association Between Migraine and Suicidal Behaviors: A Systematic Review.
  • Sphenopalatine Ganglion Block: Treatment of Migraine and Trigeminal Neuralgia Associated With Multiple Sclerosis.
  • Improving the Patient Experience With Migraine Camp, a One-Day Group Intervention for Adolescents With Chronic Headache and Their Parents.
  • Getting to the Heart of the Matter: Migraine, Triptans, DHE, Ditans, CGRP Antibodies, First/Second-Generation Gepants, and Cardiovascular Risk.
  • Lamotrigine in the Prevention of Migraine With Aura: A Narrative Review.
  • Effects of Non-invasive Brain Stimulation on Headache Intensity and Frequency of Headache Attacks in Patients With Migraine: A Systematic Review and Meta-Analysis.
  • Treatment effects on pain catastrophizing and cutaneous allodynia symptoms in women with migraine and overweight/obesity.
  • Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA.
  • Paracetamol versus Ibuprofen for the Acute Treatment of Migraine Headache in Children: A Blinded Randomized Controlled Trial – Correspondence.
  • The Efficacy and Safety of Prochlorperazine in Patients With Acute Migraine: A Systematic Review and Meta-Analysis.
  • Reduced Short-Latency Afferent Inhibition Indicates Impaired Sensorimotor Integrity During Migraine Attacks.
  • The Impact of Shift Work on Migraine: A Case Series and Narrative Review.
  • Online Migraine Education and Support for Patients: Perspectives from the American Headache Society Emerging Leaders Program.
  • Triptans for Migraine Patients With Vascular Risks: New Insights, New Options.
  • Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients.
  • Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study.
  • COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.
  • Triggers of Primary Headaches: Issues and Pathways Forward.
  • Ubrogepant to treat migraine.
  • Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients
  • Efficacy of Erenumab on Functional Impact of Migraine
  • Catechol-O-Methyltransferase Val158Met Polymorphism Is Associated with Anxiety, Depression, and Widespread Pressure Pain Sensitivity in Women with Chronic, but Not Episodic, Migraine.
  • Discovery of CGRP in relation to migraine.
  • Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme.
  • One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study.
  • Intravenous Migraine Treatment in Children and Adolescents.
  • Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine.
  • Efficacy of AJOVY (Fremanezumab-vfrm) on Interictal Migraine Related Burden
  • Metacognitive impairment in patients with episodic and chronic migraine.
  • When a Head Is about to Burst: Attachment Mediates the Relationship Between Childhood Trauma and Migraine.
  • Administrative prevalence and incidence, characteristics and prescription patterns of patients with migraine in Germany: a retrospective claims data analysis.
  • Cortical Mechanisms of Single-Pulse Transcranial Magnetic Stimulation in Migraine.
  • A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe.
  • Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks.
  • A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
  • Erenumab in highly therapy-refractory migraine patients: First German real-world evidence.
  • Burden of migraine and impact of emerging therapies on managed care.
  • [UPLC-MS/MS determination of active components from Wuzhuyu Decoction in plasma and brain tissues of nitroglycerin-induced migraine rats].
  • Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
  • PACAP and Other Neuropeptide Targets Link Chronic Migraine and Opioid-induced Hyperalgesia in Mouse Models.
  • Nutritional intervention may improve migraine severity: a pilot study.
  • The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
  • [Recommendations on the use of monoclonal antibodies for treating migraine. Consensus group of Navarre and Aragon].
  • Failure of preventive treatments in migraine: an observational retrospective study in a tertiary headache center.
  • Effect of Vestibular Rehabilitation on Spontaneous Brain Activity in Patients With Vestibular Migraine: A Resting-State Functional Magnetic Resonance Imaging Study.
  • Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.
  • Efficacy of adding midazolam to paracetamol in pain control of patients with a primary headache: A randomized, clinical trial study.
  • A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine.
  • Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study.
  • Chronic migraine and Botulinum Toxin Type A: Where do paths cross?
  • Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.
  • The Efficacy of Botulinum Toxin in Pediatric Chronic Migraine: A Literature Review.
  • Significant incidental brain magnetic resonance imaging findings in migraine headache patients: Retrospective cross-sectional study.
  • Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials.
  • Recent Advances in the Management of Migraine in Older Patients.
  • Phase clustering in transcranial magnetic stimulation-evoked EEG responses in genetic generalized epilepsy and migraine.
  • The Clinical Characteristics and Neurophysiological Assessments of the Occipital Cortex in Visual Snow Syndrome With or Without Migraine.
  • Tweeting the Headache Meetings: Cross-Sectional Analysis of Twitter Activity Surrounding American Headache Society Conferences.
  • Migraine-linked characteristics of transcranial magnetic stimulation-induced phosphenes.
  • Short-term Treatment of Migraine in Children and Adolescents.
  • Alterations in Functional Connectivity During Different Phases of the Triggered Migraine Attack.
  • Prevalence of Migraine and Neuropathic Pain in Rheumatic Diseases.
  • Headache in children with Sturge-Weber syndrome – Prevalence, associations and impact.
  • The Use of Botulinum Toxin in the Management of Headache Disorders.
  • Vestibular migraine and benign paroxysmal positional vertigo, close presentation dilemma.
  • Rimegepant (Nurtec ODT) for acute treatment of migraine.
  • Lasmiditan (Reyvow) and ubrogepant (Ubrelvy) for acute treatment of migraine.
  • Neuronavigation based 10 sessions of repetitive transcranial magnetic stimulation therapy in chronic migraine: an exploratory study.
  • Structure-Based Drug Discovery of N-((R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(((S)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2′-oxo-1′,2′-dihydrospiro[piperidine-4,4′-pyrido[2,3-d][1,3]oxazine]-1-carboxamide (HTL22562): a Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist For Acute Treatment of Migraine.
  • A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine
  • Tricaprilin Phase 2 Pilot Study in Migraine
  • CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP’s Role in Migraine with Aura.
  • Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study.
  • Migraine: The Disease of the Year.
  • Headaches in Idiopathic Intracranial Hypertension.
  • Topiramate as an Indomethacin-Sparing Agent in Hemicrania Continua: A Report of 2 Cases.
  • Calcitonin Gene-Related Protein (CGRP)-Targeted Treatments for Migraine Prevention.
  • Impaired wound healing in a migraine patient as a possible side effect of calcitonin gene-related peptide receptor antibody treatment: A case report.
  • No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse: A double blind, randomised clinical trial.
  • Patterns of pharmacological treatment of patients with migraine, tension-type headache, and cluster headache in a large group of patients in Colombia, 2019.
  • Repetitive stress in mice causes migraine-like behaviors and CGRP-dependent hyperalgesic priming to a migraine trigger.
  • Candesartan in migraine prevention: results from a retrospective real-world study.
  • Effects of dry needling technique into trigger points of the sternocleidomastoid muscle in migraine headache: A randomized controlled trial.
  • Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study.
  • Clinical Reasoning Behind Non-Pharmacological Interventions for the Management of Headaches: A Narrative Literature Review.
  • Characterizing opioid use in a US population with migraine: Results from the CaMEO study.
  • Towards eHealth to support the health journey of headache patients: a scoping review.
  • Complicated decisions on new migraine-prevention therapies.
  • Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine.
  • The role of erenumab in the treatment of migraine.
  • Gepants for abortive treatment of migraine: A network meta-analysis.
  • Should we adapt the prescription criteria for specific treatments for migraine due to the Covid-19 pandemic?
  • Single vs Multi-fraction SRS Patients on Immunotherapy
  • Effect of Acupressure in Migraine: Single-blinded, Randomized, Controlled Clinical Trial
  • Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience.
  • Sherpas, Coca Leaves, and Planes: High Altitude and Airplane Headache Review with a Case of Post-LASIK Myopic Shift.
  • Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia.
  • Calcitonin Gene-Related Peptide Receptor Antagonists (Gepants) for the Acute Treatment of Nausea in Episodic Migraine: A Systematic Review and Meta-Analysis.
  • Efficacy and safety of the classic chinese herbal prescription sanpian decoction on migraine: Meta-analysis.
  • Contract-relax technique compared to static stretching in treating migraine in women: A randomized pilot trial.
  • A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment.
  • Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis.
  • [Migraine in childhood and adolescence-neurostimulation as a future innovative approach in terms of a multimodal treatment regimen].
  • Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache.
  • A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Patients That Are Not Helped by Previous Preventive Treatments
  • The efficacy and safety of valproate medications for migraine in adults: a meta-analysis.
  • Galcanezumab for Vestibular Migraine
  • A prospective real-world analysis of erenumab in refractory chronic migraine.
  • Chronic Migraine With Apparent Loss of Response to Onabotulinum Toxin Type A Due to Local Nitroglycerin Treatment for an Anal Fissure: A Case Report.
  • Loneliness and Migraine Self-Management: A Cross-Sectional Assessment.
  • Feasibility of Smartphone-delivered Progressive Muscle Relaxation (PMR) in Persistent Post-Traumatic Headache (PPTH) Patients.
  • Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients.
  • Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain.
  • Clinical Features and Burden Scores in Japanese Pediatric Migraines With Brainstem Aura, Hemiplegic Migraine, and Retinal Migraine.
  • Comparing the Effectiveness of Neurofeedback and Transcranial Direct Current Stimulation on Sleep Quality of Patients With Migraine.
  • Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency
  • Lasmiditan for the acute treatment of migraine.
  • Fear, Avoidance, and Disability in Headache Disorders.
  • Acupuncture for Migraine: a Review of the Data and Clinical Insights.
  • Headache in the Older Population: Causes, Diagnoses, and Treatments.
  • An Unusual Cause of Chronic Headache in an Adolescent Boy: A Case Report.
  • Long-term Safety Study of BHV-3500 (Vazegepant) for the Acute Treatment of Migraine
  • Medication overuse headache: an overview of clinical aspects, mechanisms, and treatments.
  • Mitochondrial migraine; a prevalence, impact and treatment efficacy cohort study.
  • Drugs for Acute Attack of Pediatric Migraine: A Network Meta-analysis of Randomized Controlled Trials.
  • A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine
  • Association Between Migraine and Breast Cancer Risk: A Population-Based Cohort Study and Literature Review.
  • The current state of acute treatment for migraine in adults in the United States.
  • Monoclonal antibodies as a preventive therapy for migraine: A meta-analysis.
  • Treatment of Tinnitus With Migraine Medications
  • Bilateral stellate ganglion block for migraine: A case report.
  • Vestibular migraine with Wallenberg syndrome: a case report.
  • From research to clinical practice: a systematic review of the implementation of psychological interventions for chronic headache in adults.
  • Paracetamol versus Ibuprofen for the Acute Treatment of Migraine Headache in Children: A Blinded Randomized Controlled Trial.
  • Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial.
  • The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects
  • Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence.
  • Factors implicated in response to treatment/prognosis of vestibular migraine.
  • The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review.
  • Hospital Burden of Migraine in United States Adults: A 15-year National Inpatient Sample Analysis.
  • Frontal Trigger Site Deactivation for Migraine Surgical Therapy.
  • Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives.
  • Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
  • Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine.
  • Diagnostic and therapeutic aspects of hemiplegic migraine.
  • European Academy of Neurology guideline on the management of medication-overuse headache.
  • Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations.
  • Ondansetron for Acute Migraine in the Pediatric Emergency Department.
  • Effects of Different Exercise Intensities on Headache: A Systematic Review.
  • Neck-specific strengthening exercise compared with sham ultrasound when added to home-stretching exercise in patients with migraine: study protocol of a two-armed, parallel-groups randomized controlled trial.
  • Evaluation and Treatment of Primary Headaches in Adolescents.
  • Chronic migraine-cephalgia related to trigeminal artery: a case report of innovative regenerative approach.
  • A systematic review on persistent trigeminal artery, in searching for a therapeutic solution to idiopathic and unresponsive trigeminal nerve inflammations and migraines.
  • Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials.
  • A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
  • A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
  • Mechanical punctate pain threshold is associated with headache frequency and phase in patients with migraine.
  • ATP sensitive potassium (KATP) channel inhibition: A promising new drug target for migraine.
  • Emerging Treatment Options for Migraine.
  • Managing Migraine in the Times of COVID-19 Pandemic.
  • Effect of probiotic supplementation on migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials.
  • Evaluation of the concomitant use of oral preventive treatments and OnabotulinumtoxinA in chronic migraine: the PREVENBOX study.
  • Associations between migraine, celiac disease, non-celiac gluten sensitivity and activity of diamine oxidase.
  • ED and Inpatient Management of Headache in Children and Adolescents.
  • Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse
  • Migraine treatment and healthcare costs: retrospective analysis of the China Health Insurance Research Association (CHIRA) database.
  • Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality.
  • Treatment of Headache in the Emergency Department: Haloperidol in the Acute Setting (THE-HA Study): A Randomized Clinical Trial.
  • Lost productivity associated with headache and depression: a quality improvement project identifying a patient population at risk.
  • Long-Term Effect of Acupuncture on the Medical Expenditure and Risk of Depression and Anxiety in Migraine Patients: A Retrospective Cohort Study.
  • Flow Diversion Endovascular Treatment Improves Headaches in Patients with Unruptured Intracranial Aneurysms.
  • New insights in post-traumatic headache with cluster headache phenotype: a cohort study.
  • Sensory processing patterns affect headache severity among adolescents with migraine.
  • Effect of yoga as add-on therapy in migraine (CONTAIN): A randomized clinical trial.
  • Validation of a clinical examination to differentiate a cervicogenic source of headache: a diagnostic prediction model using controlled diagnostic blocks.
  • Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study.
  • Peripheral nerve stimulation registry for intractable migraine headache (RELIEF): a real-life perspective on the utility of occipital nerve stimulation for chronic migraine.
  • Migraine in the Emergency Department.
  • New Migraine Medication.
  • Impact of laser iridotomy on headache symptoms in angle-closure subjects.
  • United States Patients’ Perspective of Living With Migraine: Country-Specific Results From the Global “My Migraine Voice” Survey.
  • Intravenous metoclopramide versus dexketoprofen trometamol versus metoclopramide+ dexketoprofen trometamol in acute migraine attack in the emergency department: A randomized double-blind controlled trial.
  • Healthy Living Partnerships for Veterans With Migraine
  • Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache
  • Erenumab Efficacy on Comorbid Cluster Headache in Patients With Migraine: A Real-World Case Series.
  • Prochlorperazine for Treatment of Acute Migraines in Adults.
  • A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication.
  • Onabotulinumtoxin Type A reconstitution with preserved versus preservative-free saline in chronic migraine (B-RECON). A randomized, double-blind trial.
  • The Adaptation of Management of Chronic Migraine Patients With Medication Overuse to the Suspension of Treatment Protocols During the COVID-19 Pandemic: Lessons From a Tertiary Headache Center in Milan, Italy.
  • Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis.
  • Migraine in the Time of COVID-19.
  • Relationship between migraine headache and hematological parameters.
  • Migraine and Ischemic Stroke: Deciphering the Bidirectional Pathway.
  • [Ion channels and mechanisms of inherited disease transmission causing migraine].
  • Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data.
  • Headache medication and the COVID-19 pandemic.
  • 189 Comparison of Traditional Therapy Versus Biofeedback for Tension Type and Migraine Headaches.
  • Effects on migraine, neck pain, and head and neck posture, of temporomandibular disorder treatment: Study of a retrospective cohort.
  • Paediatric migraine with visual hallucination auras appearing in the form of a human body.
  • Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.
  • Factors Affecting Preventive Treatment Outcomes for Patients With Newly Diagnosed Chronic Migraine and Their Compliance With Treatment Recommendations in Chongqing Province, China: An Open-Label Prospective Study With Retrospective Baseline.
  • Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study.
  • Th Effect of Ketogenic Metabolic Nutritional Pattern on High-frequency Episodic Migraine (EMIKETO)
  • Alterations in Brain Function After Cognitive Behavioral Therapy for Migraine in Children and Adolescents.
  • Neuromodulation in primary headaches: current evidence and integration into clinical practice.
  • Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication Use: An Open-Label Extension Study.
  • Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review.
  • [Portfolio of services and basic table of quality indicators for Headache Units: a consensus study].
  • Associations between lifestyle intervention-related changes in dietary targets and migraine headaches among women in the Women’s Health and Migraine (WHAM) randomized controlled trial.
  • Herbal treatments for migraine: A systematic review of randomised-controlled studies.
  • Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
  • Cross-trait analyses with migraine reveal widespread pleiotropy and suggest a vascular component to migraine headache.
  • Reduction in Migraine and Headache Frequency and Intensity with Combined Antioxidant Prophylaxis (N-acetylcysteine, Vitamin E and Vitamin C: NEC): A Randomized Sham-Controlled Pilot Study.
  • Unmet needs in the acute treatment of migraine attacks and the emerging role of calcitonin gene-related peptide receptor antagonists: An integrative review.
  • Opioid Use to Treat Migraine Headaches in Hospitalized Children and Adolescents.
  • Primary Exercise Headache.
  • Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units?
  • Subjective benign paroxysmal positional vertigo in patients with osteoporosis or migraine.
  • Can verapamil be effective in controlling vertigo and headache attacks in vestibular migraine accompanied with Meniere’s disease? A preliminary study.
  • Stroke-Like Migraine Attacks After Radiation Therapy Syndrome.
  • Management of Ménière’s Disease: How Does the Coexistence of Vestibular Migraine Affect Outcomes?
  • Persistent Post-Traumatic Headache and Migraine: Pre-Clinical Comparisons.
  • [Headache and Vertigo].
  • Vestibular migraine – an underdiagnosed cause of vertigo. Diagnosis and treatment.
  • Economic evaluations in migraine: Systematic literature review and a novel approach.
  • Effectiveness of cathodal tDCS of the primary motor or sensory cortex in migraine: A randomized controlled trial.
  • Short-term cortical synaptic depression/potentiation mechanisms in chronic migraine patients with or without medication overuse.
  • The association between migraine and hospital readmission due to pain after surgery: A hospital registry study.
  • NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice.
  • Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches
  • Effectiveness and Safety of Acupuncture for Migraine: An Overview of Systematic Reviews.
  • Overuse of opioids for acute migraine in an Australian emergency department.
  • Predictive Value of Vestibular Evoked Myogenic Potentials in the Diagnosis of Menière’s Disease and Vestibular Migraine.
  • Onabotulinumtoxin A Injections for Chronic Migraine Prophylaxis.
  • Migraine in 746 patients with multiple sclerosis.
  • Headache Outcomes After Treatment of Unruptured Intracranial Aneurysm: A Systematic Review and Meta-Analysis.
  • SEEDS for success: Lifestyle management in migraine.
  • Manual acupuncture for migraine.
  • Sex-Specific Pharmacotherapy for Migraine: A Narrative Review.
  • Anti-CGRP in cluster headache therapy: a response.
  • A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.
  • Impact of the botulinum-A toxin on prevention of adult migraine disorders.
  • Anodal tDCS in Chronic Migraine With Medication Overuse
  • Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?
  • Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
  • Migraine and Ischemic Stroke in Women. A Narrative Review.
  • CGRP pathway monoclonal antibodies for Cluster Headache.
  • Adjuvant Migraine Medications in the Treatment of Sudden Sensorineural Hearing Loss.
  • Erenumab (Aimovig) for Migraine Prophylaxis in Adults.
  • Cognitive impairment in chronic migraine: a cross-sectional study in a clinic-based sample.
  • CGRP antagonists for decreasing migraine frequency: New options, long overdue.
  • State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study.
  • Frequent Headaches: Evaluation and Management.
  • Multiple Cranial Nerve Blocks as an Alternative Preventative Therapy for Chronic Migraine.
  • The Many Faces of Medication-Overuse Headache in Clinical Practice.
  • Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.
  • An Evidence-Based Review of Fremanezumab for the Treatment of Migraine.
  • SMART (Stroke-Like Migraine Attacks After Radiation Therapy) Syndrome: A Case Study with Imaging Supporting the Theory of Vascular Dysfunction.
  • Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
  • Subcutaneous sumatriptan reduces cilostazol induced headache in migraine patients.
  • Migraine and risk of stroke.
  • Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial.
  • Dynamic Pressure Pain Hypersensitivity as Assessed by Roller Pressure Algometry in Episodic Cluster Headache.
  • Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.
  • Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS Expert Consensus Panel Review and Recommendation.
  • Behavioral Therapy Preferences in People With Migraine.
  • Mindfulness During COVID-19
  • Sociodemographic Factors Associated With Hospital Care for Pediatric Migraine: A National Study Using the Kids’ Inpatient Dataset.
  • Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management.
  • Stroke-Like Migraine Attacks After Radiation Therapy (SMART) Syndrome: A Rare, Reversible Complication of Radiation Therapy.
  • A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches.
  • Migraine Pathophysiology.
  • Safety and Efficacy of Ubrogepant for the Acute Treatment of Episodic Migraine: A Meta-Analysis of Randomized Clinical Trials.
  • Baseline Brain Gray Matter Volume as a Predictor of Acupuncture Outcome in Treating Migraine.
  • Inhibition of Trigeminal Nociception by Non-invasive Vagus Nerve Stimulation: Investigating the Role of GABAergic and Serotonergic Pathways in a Model of Episodic Migraine.
  • Emerging relevance of circadian rhythms in headaches and neuropathic pain.
  • Emergency Department and Inpatient Management of Headache in Adults.
  • Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis.
  • A case of late-onset sporadic hemiplegic migraine.
  • Enhanced mindfulness based stress reduction (MBSR+) in episodic migraine: a randomized clinical trial with MRI outcomes.
  • Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials.
  • Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans.
  • Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention.
  • Development and Validation of VM-PATHI: Vestibular Migraine Patient Assessment Tool and Handicap Inventory.
  • Rapid referral for headache management from emergency department to headache centre: four years data.
  • Vitamins and Minerals for Migraine Prophylaxis: A Systematic Review and Meta-analysis.
  • New Guidelines for Prevention and Treatment of Migraines in Children.
  • Migraine and Sleep in Children: A Bidirectional Relationship.
  • Cervical Noninvasive Vagus Nerve Stimulation for Migraine and Cluster Headache: A Systematic Review and Meta-Analysis.
  • Ultrasound-Guided Perisutural Botulinum Toxin Injection for Chronic Migraine Headache: Initial Report With Technical Description.
  • Probiotics for the Prophylaxis of Migraine
  • Cathodal tDCS Guided by Thermography as Adjunctive Therapy in Chronic Migraine Patients: A Sham-Controlled Pilot Study.
  • Medication overuse headache in 787 patients admitted for inpatient treatment over a period of 32 years.
  • Population pharmacokinetic and exposure-response analysis of eptinezumab in the treatment of episodic and chronic migraine.
  • The Efficacy of Topical Basil Essential Oil on Relieving Migraine Headaches: A Randomized Triple-Blind Study.
  • A Study of Clinical Features and Risk Factors of Self-Referring Emergency Department Headache Patients: A Comparison with Headache Center Outpatients.
  • Recent Medications Approved for Preventing Migraine Headaches.
  • Acute treatment patterns in patients with migraine newly initiating a triptan.
  • Prolonged Migraine Stuttering Aura: Structural, Functional, and Video Neuroimaging Study of an Atypical Migraine Aura. A Case Report.
  • PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?
  • Trigeminal autonomic cephalgia: A rare cause of headache in children.
  • Spatial Distribution of Temporalis Pressure Pain Sensitivity in Men with Episodic Cluster Headache.
  • Acupuncture for menstrual migraine: a systematic review.
  • Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
  • A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a CGRP Antagonist
  • Migraine Treatment.
  • A comprehensive overview and safety evaluation of fremanezumab as a preventive therapy for migraine.
  • Digital Cognitive Behavioral Therapy for Insomnia in Women With Chronic Migraines.
  • To Eat or Not to Eat: A Review of the Relationship between Chocolate and Migraines.
  • Proteomic serum profile in menstrual-related and post menopause migraine.
  • Concomitant medical conditions and total cost of care in patients with migraine: a real-world claims analysis.
  • Real-world assessment of concomitant opioid utilization and associated trends in patients with migraine.
  • Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma.
  • Persistent post-traumatic headache attributed to mild traumatic brain injury: Deep phenotyping and treatment patterns.
  • [Migraine burden and clinical inertia: what can we do?]
  • The Effect of Intravenous Fluid Therapy in Acute Migraine Attacks
  • Acute Dystonic Reactions in Children Treated for Headache With Prochlorperazine or Metoclopramide.
  • Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study.
  • Acceptance and Commitment Therapy (ACT) vs Erenumab for High Frequency Episodic Migraine Without Aura: Time to Take the Gloves Off!
  • A Head-to-Head Comparison of Percutaneous Mastoid Electrical Stimulator and Supraorbital Transcutaneous Stimulator in the Prevention of Migraine: A Prospective, Randomized Controlled Study.
  • Diagnosing and managing migraine in children and young people.
  • The impact of external trigeminal nerve stimulator (e-TNS) on prevention and acute treatment of episodic and chronic migraine: A systematic review.
  • Discussion: Migraine Surgery at the Frontal Trigger Site: An Analysis of Intraoperative Anatomy.
  • Studies on the Mechanism of Glutamate Metabolism in NTG-Induced Migraine Rats Treated with DCXF.
  • Structural and Functional Characterization of the Gut Microbiota in Elderly Women With Migraine.
  • Treatment of Vestibular Migraine: A Systematic Review and Meta-analysis.
  • Topical Beta Blockers for the Treatment of Acute Migraines in 2019.
  • Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).
  • Enhanced post-traumatic headache-like behaviors and diminished contribution of peripheral CGRP in female rats following a mild closed head injury.
  • Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department
  • Development of a measure to assess acceptance of headache: The Headache Acceptance Questionnaire (HAQ).
  • The Post-Pipeline Headache: New Headaches Following Flow Diversion for Intracranial Aneurysm.
  • [Modern migraine therapy-interdisciplinary long-term care].
  • Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II.
  • Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients.
  • Public policies in headache disorders: needs and possibilities.
  • Effectiveness of a Dialogue-based Online Intervention Against A) Tension-type Headache and B) Migraine
  • Altered lateral geniculate nucleus functional connectivity in migraine without aura: a resting-state functional MRI study.
  • Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice.
  • Metabolic treatments of migraine.
  • How Does Migraine Change After 10 Years? A Clinical Cohort Follow-Up Analysis.
  • Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – an updated systematic review and meta-analysis.
  • Care Among Migraine Patients in a Commercially Insured Population.
  • Do doctors treat themselves differently than their patients? Study on the self-treatment of migraine among German neurologists and pain specialists.
  • Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
  • Cognitive Function and Autonomic Regulation in Patients With Migraine
  • Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache.
  • The effect of greater occipital nerve blockade on the quality of life, disability and comorbid depression, anxiety, and sleep disturbance in patients with chronic migraine.
  • Have the IHS Guidelines for controlled trials of acute treatment of migraine attacks been followed? Laying the ground for the 4th edition.
  • Prospective Double-Blinded Randomized Field-Based Clinical Trial of Metoclopramide and Ibuprofen for the Treatment of High Altitude Headache and Acute Mountain Sickness.
  • Blocking the CGRP Pathway for Acute and Preventative Treatment of Migraine – The Evolution of Success.
  • Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
  • Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.
  • Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study.
  • Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy.
  • Response to “Do different treatment strategies of galcanezumab have similar effect on migraine?”
  • [A teenager with a rare cause of migraine-like headaches and neurological deficits – syndrome of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis].
  • Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study.
  • Treatment Patterns and Unmet Needs in the Acute Treatment of Migraine.
  • Pharmacology and Pharmacokinetics of Ubrogepant: A Potent, Selective Calcitonin Gene-Related Peptide Receptor Antagonist for the Acute Treatment of Migraine.
  • Clinical Efficacy and Safety of Ubrogepant for the Acute Treatment of Migraine.
  • Treatment Patterns and Unmet Needs in the Acute Treatment of Migraine.
  • Pharmacology and Pharmacokinetics of Ubrogepant: A Potent, Selective Calcitonin Gene-Related Peptide Receptor Antagonist for the Acute Treatment of Migraine.
  • Clinical Efficacy and Safety of Ubrogepant for the Acute Treatment of Migraine.
  • Different doses of galcanezumab versus placebo in patients with migraine and cluster headache: a meta-analysis of randomized controlled trials.
  • Noninvasive vagus nerve stimulation in a primary care setting: effects on quality of life and utilization measures in multimorbidity patients with or without primary headache.
  • Molecular Insight into Recognition of the CGRPR Complex by Migraine Prevention Therapy Aimovig (Erenumab).
  • Biomarker and Genetic Predictors of Erenumab Treatment Response
  • The Integrative Migraine Pain Alleviation through Chiropractic Therapy (IMPACT) trial: Study rationale, design and intervention validation.
  • [Argentinean consensus guidelines on the use of monoclonal antibodies in patients with migraine].
  • Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.
  • Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application.
  • Psychopharmacology of headache and its psychiatric comorbidities.
  • Late sodium current blocker GS967 inhibits persistent currents induced by familial hemiplegic migraine type 3 mutations of the SCN1A gene.
  • Headache and Methemoglobinemia.
  • [Observation on therapeutic effect and mechanism research of acupuncture on headache in the recovery phase of ischemic stroke].
  • Aspirin in the Treatment and Prevention of Migraine Headaches: Possible Additional Clinical Options for Primary Healthcare Providers.
  • Can physical testing be used to distinguish between migraine and cervicogenic headache sufferers? A protocol for a systematic review.
  • Altered functional connectivity of the red nucleus and substantia nigra in migraine without aura.
  • A Cross-Sectional Analysis of Migraine-Related Disability in CADASIL: A Mayo Clinic Cohort.
  • Fremanezumab in the treatment of migraines: evidence to date.
  • ACR Appropriateness Criteria® Headache.
  • Headaches in the emergency department -a survey of patients’ characteristics, facts and needs.
  • Positional Patterns Among the Auriculotemporal Nerve, Superficial Temporal Artery, and Superficial Temporal Vein for use in Decompression Treatments for Migraine.
  • Efficacy of electrical stimulation for treatment of migraine.
  • Spatial Distribution of Temporalis Pressure Pain Sensitivity in Men with Episodic Cluster Headache.
  • Novelty in Inflammation and Immunomodulation in Migraine.
  • Comparison of the Effect of Tanacethum Parthenium, 5-Hydroxy Tryptophan, and Magnesium (Aurastop) versus Magnesium Alone on Aura Phenomenon and Its Evolution.
  • Association Between Personality Traits and Onabotulinumtoxin A Response in Patients With Chronic Migraine.
  • Efficacy of Galcanezumab in Patients with Episodic Migraine and a History of Preventive Treatment Failure: Results from Two Global Randomized Clinical Trials.
  • Idebenone for the Preventive Treatment of Migraine
  • Evaluate Efficacy & Safety of Eptinezumab Administered Intravenously in Subjects Experiencing Acute Attack of Migraine
  • Aromatherapy Massage in Migraine Attacks
  • Neuroimaging features of whole-brain functional connectivity predict attack frequency of migraine.
  • Relationship Between Headaches and Neck Pain Characteristics With Neck Muscle Strength.
  • External trigeminal nerve stimulation: Potential rescue treatment for acute vestibular migraine.
  • Subgrouping Factors influencing Migraine Intensity in Women: A Semi-automatic Methodology based on Machine Learning and Information Geometry.
  • Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.
  • Extensive linear scleroderma en coup de sabre with exertion-induced hemiplegic migraine.
  • Yoga for Treating Headaches: a Systematic Review and Meta-analysis.
  • The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal.
  • Rimegepant in the Treatment of Migraine Headache: The Importance of Comparator Treatments: November 2019 Annals of Emergency Medicine Journal Club.
  • Targeting calcitonin gene-related peptide: a new era in migraine therapy.
  • Continue or stop applying wet cupping therapy (al-hijamah) in migraine headache:A randomized controlled trial.
  • Episodic primary migraine headache: prophylaxis with Pycnogenol® precents attacks and controls oxidative stress.
  • Pharmacologic Treatment of Pediatric Migraine Prevention.
  • Acute Treatment of Migraine in Children and Adolescents.
  • Migraine: Expanding our Tx arsenal.
  • Response To: ‘Therapeutic Role of Fat Injection in the Treatment of Recalcitrant Migraine Headaches.’
  • Is There Any Correlation between Migraine Attacks and Iron Deficiency Anemia? A Case-Control Study.
  • BOTULINUM TOXIN INJECTIONS TO CRANIAL SUTURES FOR CHRONIC MIGRAINE Rewinding the Technique Using Ultrasound Imaging.
  • Paranasal sinus air suction for immediate pain relief of acute migraine – a randomized, double blind pilot study.
  • Could inhaled drug formulations be the future of acute migraine treatment?
  • Transcutaneous auricular vagus nerve stimulation at 1 Hz modulates locus coeruleus activity and resting state functional connectivity in patients with migraine: An fMRI study.
  • Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
  • Intranasal lidocaine for acute migraine: A meta-analysis of randomized controlled trials.
  • PD-L1 and PD-1 expressed in trigeminal ganglia may inhibit pain in an acute migraine model.
  • Swollen and bloodshot eye following headache.
  • The future of pharmacogenetics in the treatment of migraine.
  • Self-medication for migraine: A nationwide cross-sectional study in Italy.
  • Plasma Levels of Oxidative Stress Markers, before and after BoNT/A Treatment, in Chronic Migraine.
  • Altered activity in the nucleus raphe magnus underlies cortical hyperexcitability and facilitates trigeminal nociception in a rat model of medication overuse headache.
  • FAAH inhibition as a preventive treatment for migraine: A pre-clinical study.
  • Primary trochlear headache. A periorbital pain with a specific diagnosis and treatment.
  • A hypothetical proposal for association between migraine and Meniere’s disease.
  • Enhancing Outpatient Dihydroergotamine Infusion With Interdisciplinary Care to Treat Refractory Pediatric Migraine: Preliminary Outcomes From the Comprehensive Aggressive Migraine Protocol (“CAMP”).
  • Plasma levels of inflammatory mediators in vestibular migraine.
  • Sumatriptan Induced Takotsubo Cardiomyopathy; the Headache of the Heart: A Case Report.
  • Propofol for treatment of acute migraine in the emergency department: a systematic review.
  • Transnasal Therapy for Acute Migraine Attack
  • Primary headache characters and coping strategies among medical students of Umm Al-Qura University in the Western Region of Saudi Arabia.
  • The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches.
  • Cortical Laminar Necrosis as a Presenting Manifestation of Migraine in an Apparently Normal Patient: A Rare Case Report.
  • A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults.
  • Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment.
  • Migraine management: beyond pills.
  • Better evidence needed for preventing paediatric migraine.
  • Cinema-like sensory phenomena in a migraine patient on topiramate.
  • Acupuncture methods for acute migraine attack: a Bayesian network meta-analysis protocol.
  • What is Needed for Evidence-Based Dietary Recommendations for Migraine: A Call to Action for Nutrition and Microbiome Research.
  • A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study.
  • Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
  • Prochlorperazine for treatment of acute migraines in adults.
  • Intranasal Spray Formulation Containing Rizatriptan benzoate for the Treatment of Migraine.
  • Bilateral Visual Field Loss in an Adolescent Girl With Migraine Headaches.
  • Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study.
  • Novel missense mutation in the ATP1A2 gene associated with atypical sporapedic hemiplegic migraine.
  • The metabolic face of migraine – from pathophysiology to treatment.
  • Self-motion perception is sensitized in vestibular migraine: pathophysiologic and clinical implications.
  • Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK.
  • Epidemiology and Treatment of Menstrual Migraine and Migraine During Pregnancy and Lactation: A Narrative Review.
  • Percutaneous electrical nerve stimulation (PENS) therapy for refractory primary headache disorders: a pilot study.
  • The treatment efficacy of galcanezumab for migraine: A meta-analysis of randomized controlled trials.
  • Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab
  • Dexamethasone for Migraine – Dose Comparison
  • Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
  • Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort.
  • Effectiveness of dry needling for improving pain and disability in adults with tension-type, cervicogenic, or migraine headaches: protocol for a systematic review.
  • Adrenomedullin Effect on Migraine Without Patients
  • Intravenous Magnesium Sulfate to Treat Acute Headaches in the Emergency Department: A Systematic Review.
  • Greater Occipital Nerve Block for the Treatment of Chronic Migraine Headaches: A Systematic Review and Meta-Analysis.
  • Discussion: Greater Occipital Nerve Block for the Treatment of Chronic Migraine Headaches: A Systematic Review and Meta-Analysis.
  • Migraine: Epidemiology, Burden, and Comorbidity.
  • Preventive Treatment for Episodic Migraine.
  • Vestibular Migraine.
  • Inpatient Management of Migraine.
  • Acute Treatment of Migraine.
  • Migraine in Women.
  • Pharmacokinetic comparative study of tetramethylpyrazine and ferulic acid and their compatibility with different concentration of gastrodin and gastrodigenin on blood-stasis migraine model by blood-brain microdialysis method.
  • Pediatric Migraine: An Update.
  • Behavioral Interventions for Migraine.
  • Migraine Awareness in Italy and the Myth of “Cervical Arthrosis”.
  • Migraine in children.
  • CGRP-based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?
  • FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
  • Novel Medications for the Treatment of Migraine.
  • Efficacy of a Novel App-based Migraine Treatment Platform – a Pilot Study
  • Cluster Headache and Calcitonin Gene-Related Peptide-More on Quantum Therapeutics in Headache Medicine.
  • Who Should Try New Antibody Treatments for Migraine?
  • Management of Childhood Migraine by Headache Specialist vs Non-Headache Specialists.
  • An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients.
  • Acute vestibular migraine treatment with noninvasive vagus nerve stimulation.
  • Recent Advances in Pharmacotherapy for Episodic Migraine.
  • Reduced Visual Quality of Life Associated with Migraine is Most Closely Correlated with Symptoms of Dry Eye.
  • Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial.
  • Single Ascending Dose Study to Investigate the Safety and Pharmacokinetics of XC101-D13H in Healthy Adult Subjects
  • Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
  • CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.
  • Monoclonal antibodies for the prevention of migraine.
  • BET 2: Treating migraines with diclofenac instead of a triptan.
  • Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
  • IFNγ-Stimulated Dendritic Cell Exosomes for Treatment of Migraine Modeled Using Spreading Depression.
  • Problematic presentation and use of efficacy measures in current trials of CGRP monoclonal antibodies for episodic migraine prevention: A mini-review.
  • Dysautonomia and Headache in the Pediatric Population.
  • A Phase II Study of Sepranolone in Women With Menstrual Migraine
  • GORE® CARDIOFORM Septal Occluder Migraine Clinical Study: A Study to Evaluate the Safety and Efficacy of Transcatheter Closure of Patent Foramen Ovale for Relief of Migraine Headaches
  • Vancouver Declaration on Global Headache Patient Advocacy 2018.
  • Headache at the emergency room: Etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags.
  • Diagnosis of Common Headaches Using Hybrid Expert-Based Systems.
  • Characterization of Familial and Sporadic Migraine.
  • Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
  • Proposed new diagnostic criteria for chronic migraine.
  • Chronic migraine headache and multiple dental pathologies causing cranial pain for 35 years: the neurodental nexus.
  • Headache symptom modification: the relevance of appropriate manual therapy assessment and management of a patient with features of migraine and cervicogenic headache – a case report.
  • [Ion channels and mechanisms of inherited disease transmission causing migraine].
  • Circadian Variation of Migraine Attack Onset: A Review of Clinical Studies.
  • Headache in Petrous Apicitis: A Case Report of Chronic Migraine-like Headache Due to Peripheral Pathology.
  • Identifying and managing acute migraine attacks in adults.
  • Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
  • Post-traumatic headache: epidemiology and pathophysiological insights.
  • Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
  • Effects of Diet Based on IgG Elimination Combined with Probiotics on Migraine Plus Irritable Bowel Syndrome.
  • Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies.
  • [Effect of otopoint pellet-pressing combined with medication on clinical symptoms of migraine patients and changes of plasma 5-HT and CGRP contents].
  • Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea
  • Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
  • Migraine and gastric disorders: Are they associated?
  • OnabotulinumtoxinA Wear-off Phenomenon in the Treatment of Chronic Migraine.
  • Botulinum Toxin versus Placebo: A Meta- Analysis of Prophylactic Treatment for Migraine.
  • A reanalysis of a randomized trial on meditation for migraine headaches: Distraction is not enough but meditation takes time.
  • Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.
  • Inhibition of gap junctional intercellular communication by an anti-migraine agent, flunarizine.
  • Computerized Rotational Head Impulse Test-Vertical (crHIT-vertical)
  • Management of Childhood Headache in the Emergency Department. Review of the Literature.
  • A Midbrain Circuit that Mediates Headache Aversiveness in Rats.
  • [investigation on the triggers and the effect of healthy education on recurrence of vestibular migraine].
  • Commentary on: Cost-Utility Analysis of Surgical Decompression Relative to Injection Therapy for Chronic Migraine Headaches.
  • Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
  • Varicella zoster encephalitis in an immunocompromised patient presented with migraine type headache: A case report.
  • Quantification of Trigeminovascular Hypersensitivity in a Chronic Migraine Patient Using Laser Speckle Contrast Analysis (LASCA).
  • Prognosis Following Discontinuation of OnabotulinumA Therapy in “Super-responding” Chronic Migraine Patients.
  • Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs.
  • Effectiveness of the traditional Japanese Kampo medicine Yokukansan for chronic migraine: A case report.
  • Multiple pharmacological and toxicological investigations on Tanacetum parthenium and Salix alba extracts: Focus on potential application as anti-migraine agents.
  • Primary headache and migraine in headache specialists – does personal history of doctors matter?
  • Heartmath Migraine Study
  • A Prospective Observational Cohort Study on Pharmacological Habitus, Headache-Related Disability and Psychological Profile in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylactic Treatment.
  • Current and emerging evidence-based treatment options in chronic migraine: a narrative review.
  • A Chinese Prescription Chuanxiong Chatiao San for Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
  • Chronic cannabis use and treatment failure of onabotulinum toxin A for chronic migraine.
  • Episodic and chronic migraine in children.
  • Acupuncture in Adult and Pediatric Headache: A Narrative Review.
  • Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials.
  • Prevalence and comorbidity of migraine headache: results from the Singapore Mental Health Study 2016.
  • Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine.
  • Chronic Migraine – Evolution of the Concept and Clinical Implications.
  • CGRP Antibodies as Prophylaxis in Migraine.
  • Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.
  • A randomized trial of telemedicine for migraine management.
  • Migraine associated with gastrointestinal disorders: A pathophysiological explanation.
  • Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience.
  • Vibratory Stimulation for the Treatment of Chronic Pain
  • Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine
  • Stroke-Like Migraine Attacks after Radiation Therapy Syndrome: Clinical and Imaging Characteristics.
  • Efficacy of triptans for the treatment of acute migraines: a quantitative comparison based on the dose-effect and time-course characteristics.
  • Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
  • Structured Clinical Documentation to Improve Quality and Support Practice-Based Research in Headache.
  • [Monoclonal antibodies for targeted migraine prevention].
  • Migraine and cerebrovascular diseases: Epidemiology, pathophysiological, and clinical considerations.
  • Acupuncture versus propranolol in migraine prophylaxis: an indirect treatment comparison meta-analysis.
  • Comment: Noninvasive neurostimulation for migraine should be part of the general neurologist’s therapeutic armamentarium.
  • Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study).
  • Auditory brainstem function in women with vestibular migraine: a controlled study.
  • The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine
  • Evaluation of Efficacy and Safety of add-on Alpha-lipoic Acid on Migraine Prophylaxis in Adolescent Population: A Randomized Controlled Trial
  • ASIC Channels and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
  • Meningeal contribution to migraine pain: a magnetic resonance angiography study.
  • Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.
  • Factors Associated with Migraine in the General Population of Spain: Results from the European Health Survey 2014.
  • Rhynchophylline attenuates migraine in trigeminal nucleus caudalis in nitroglycerin-induced rat model by inhibiting MAPK/NF-кB signaling.
  • Inter-rater agreement in the choice of prophylactic treatment for vestibular migraine and role of an assisted algorithm for this choice.
  • Predicting initiation of preventive migraine medications: exploratory study in a large U.S. medical claims database.
  • Pharmacologic Management of Acute Migraines in the Emergency Department.
  • Migraine patients’ journey until a tertiary headache center: an observational study.
  • Population pharmacokinetic modeling and simulation of fremanezumab in healthy subjects and patients with migraine.
  • Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
  • Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
  • Effects of occlusal splint therapy in patients with migraine or tension-type headache and comorbid temporomandibular disorder: A randomized controlled trial.
  • Aids to management of headache disorders in primary care (2nd edition) : on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache.
  • Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN).
  • Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
  • Human models of migraine – short-term pain for long-term gain.
  • Noninvasive Vagal Nerve Stimulation in Chronic Migraine with Medication Overuse Headache.
  • Identification of Everyday Sounds Perceived as Noise by Migraine Patients.
  • Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model.
  • Comparing the Effect of Intranasal Lidocaine 4% with Peppermint Essential Oil Drop 1.5% on Migraine Attacks: A Double-Blind Clinical Trial.
  • Complementary and Integrative Health Treatments for Migraine.
  • [Neurophysiological approaches to the diagnosis and treatment of vestibular disorders in migraine and epilepsy].
  • Prevalence and factors associated with the use of primary headache diagnostic criteria by chiropractors.
  • Manual Therapy and Quality of Life in People with Headache: Systematic Review and Meta-analysis of Randomized Controlled Trials.
  • Migraine History: A Predictor of Negative Diffusion-Weighted Imaging in IV-tPA-Treated Stroke Mimics.
  • Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines.
  • Double-blind placebo-controlled randomized clinical trial of ginger (Zingiber officinale Rosc.) in the prophylactic treatment of migraine.
  • Extensor/flexor ratio of neck muscle strength and electromyographic activity of individuals with migraine: a cross-sectional study.
  • Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial.
  • Vestibular migraine: An update on current understanding and future directions.
  • Message Framing and the Willingness to Pursue Behavioral Therapy: A Study of People With Migraine.
  • The Role of Anti-calcitonin Gene-related Peptide in Migraine and its Implication in Developing Countries: A Reasonable Option to Consider Despite Higher Cost.
  • [Status quo and thinking of acupoint optimization for preventive treatment of migraine].
  • What’s New in the Treatment of Migraine.
Back to top